发明名称 |
Compositions and methods of treating T cell mediated disorder |
摘要 |
A method of generating a CD4+FoxP3+ Treg cell, the method includes administering at least one complement antagonist to a naive CD4+ T cell at an amount effective to substantially inhibits C3a receptor (C3aR) and/or C5a receptor (C5aR) signal transduction in the CD4+ T cell, induce TGF-β1 expression of the CD4+ T cell, and induce differentiation of the of the naive CD4+ T cell into a CD4+FoxP3+ Treg cell. |
申请公布号 |
US9290736(B2) |
申请公布日期 |
2016.03.22 |
申请号 |
US201013505976 |
申请日期 |
2010.11.04 |
申请人 |
Case Western Reserve University |
发明人 |
Medof M. Edward;Lin Feng;Strainic Michael G. |
分类号 |
C12N5/071;C12N5/00;C12N5/02;C12N5/0783;A61K38/00;A61K35/12 |
主分类号 |
C12N5/071 |
代理机构 |
Tarolli, Sundheim, Covell & Tummino LLP |
代理人 |
Tarolli, Sundheim, Covell & Tummino LLP |
主权项 |
1. A method of generating a CD4+FoxP3+ Treg cell, the method comprising:
isolating a naive CD4+ T cell; culturing the naive CD4+ T cell in the presence of dendritic cells or antigen presenting cells, anti-CD3, and IL 2; and administering a C3a antagonist or C3aR antagonist and a C5a antagonist or C5aR antagonist to the naive CD4+ T cell at an amount effective to substantially inhibit interaction of C3a and C5a with the C3aR and C5aR of the CD4+ T cell, induce TGF-β1 expression of the CD4+ T cell, and induce differentiation of the of the naive CD4+ T cell into a CD4+FoxP3+ Treg cell. |
地址 |
Cleveland OH US |